10:46:28 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-17 Kvartalsrapport 2024-Q3
2024-07-12 Kvartalsrapport 2024-Q2
2024-04-19 Ordinarie utdelning ARJO B 0.90 SEK
2024-04-18 Kvartalsrapport 2024-Q1
2024-04-18 Årsstämma 2024
2024-01-30 Bokslutskommuniké 2023
2023-10-19 Kvartalsrapport 2023-Q3
2023-07-13 Kvartalsrapport 2023-Q2
2023-07-12 Kvartalsrapport 2023-Q2
2023-04-21 Ordinarie utdelning ARJO B 0.85 SEK
2023-04-20 Kvartalsrapport 2023-Q1
2023-04-20 Årsstämma 2023
2023-01-25 Bokslutskommuniké 2022
2022-10-28 Kvartalsrapport 2022-Q3
2022-07-14 Kvartalsrapport 2022-Q2
2022-04-25 Ordinarie utdelning ARJO B 1.15 SEK
2022-04-22 Kvartalsrapport 2022-Q1
2022-04-22 Årsstämma 2022
2022-02-03 Bokslutskommuniké 2021
2021-10-28 Kvartalsrapport 2021-Q3
2021-07-15 Kvartalsrapport 2021-Q2
2021-04-28 Ordinarie utdelning ARJO B 0.85 SEK
2021-04-27 Kvartalsrapport 2021-Q1
2021-04-27 Årsstämma 2021
2021-02-03 Bokslutskommuniké 2020
2020-10-28 Kvartalsrapport 2020-Q3
2020-07-17 Kvartalsrapport 2020-Q2
2020-06-30 Ordinarie utdelning ARJO B 0.65 SEK
2020-06-29 Årsstämma 2020
2020-04-27 Kvartalsrapport 2020-Q1
2020-02-04 Bokslutskommuniké 2019
2019-10-22 Kvartalsrapport 2019-Q3
2019-07-18 Kvartalsrapport 2019-Q2
2019-05-08 Ordinarie utdelning ARJO B 0.55 SEK
2019-05-07 Årsstämma 2019
2019-05-07 Kvartalsrapport 2019-Q1
2019-02-04 Bokslutskommuniké 2018
2018-10-22 Kvartalsrapport 2018-Q3
2018-07-19 Kvartalsrapport 2018-Q2
2018-05-07 Ordinarie utdelning ARJO B 0.50 SEK
2018-05-04 Kvartalsrapport 2018-Q1
2018-05-04 Årsstämma 2018
2018-01-29 Bokslutskommuniké 2017

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Arjo är ett globalt bolag med verksamhet inom sjukvårdsindustrin. Bolaget är idag specialiserade inom utvecklingen av medicintekniska produkter. Produktportföljen är bred och inkluderar exempelvis sjukvårdssängar, golv- och taklyftar, desinfektionslösningar, samt av hygienprodukter och kompressionslösningar. Utöver erbjuds service och tillhörande tjänster samt utbildning. Störst verksamhet återfinns inom Europa och Nordamerika.
2021-07-15 07:00:00

"We close another strong quarter and grow organically by 4,0%, supported by a solid order intake. We successfully navigate the Covid-19 challenges and see a continued recovery within profitable categories like patient handling, service and DVT. Our profitability continues to improve and we report an adjusted EBITDA-margin exceeding 23% for the first time," says Joacim Lindoff, President & CEO.

"The implementation of our long-term strategy continues with full force, at the same time as we are delivering on our short-term targets. Our newly launched SEM scanner is generating high interest and we currently have more than 150 evaluations planned or completed by customers around the world. In summary, we add a strong quarter to the books and maintain a positive outlook for our performance over the coming quarters," concludes Joacim Lindoff.

April-June 2021 in brief
  • Net sales amounted to SEK 2,199 M (2,264).
Net sales grew organically by 4.0%.
  • Adjusted EBITDA increased 4.9% to SEK 513 M (489).
In comparable currencies, profit was SEK 546 M, corresponding to an improvement of about 12%.
  • Adjusted operating profit increased by 12.8% to SEK 275 M (244).
In comparable currencies, profit was SEK 295 M, corresponding to an improvement of about 21%.
  • Profit after financial items increased to SEK 253 M (152).
  • Earnings per share rose to SEK 0.70 (0.42).
  • Cash flow from operations amounted to SEK 431 M (613).
  • Acquisition of South African rental operations specializing in pressure injury prevention.

Telephone conference

Fund managers, analysts and the media are invited to a teleconference on July 15 at 08.00 CET. Please see details below to join the conference:

Sweden: +46 8 505 583 59

USA: +1 646 722 4956

UK: +44 333 300 9265

A presentation will be held during the telephone conference. To access the presentation, please use this link: https://tv.streamfabriken.com/arjo-q2-2020
Alternatively, use the following link to download the presentation:
https://www.arjo.com/int/about-us/investors/reports--presentations/2021/
A recording of the teleconference will be available for 90 days via the following link: https://tv.streamfabriken.com/arjo-q2-2020

For more information, please contact:

Kornelia Rasmussen
Executive Vice President, Marketing Communications & Public Relations
Tel: +46 (0)10 335 4810
Email: kornelia.rasmussen@arjo.com

Maria Nilsson
Investor Relations & Corporate Communications
Tel: +46 (0)10 335 4866
Email: maria.nilsson@arjo.com

This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CET on July 15, 2021.
 

About Arjo

At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With over 6,000 people worldwide and 60 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com